In vivo effects of vitamin D on the proliferation and differentiation of rat keratinocytes.
The hormonal form of vitamin D appears to be a physiological regulator of the epidermogenesis. While its differentiation-promoting effect is well accepted, there are conflicting reports of its action on keratinocyte proliferation. This study evaluates the specific changes induced by vitamin D treatment in the epidermis of rats nutritionally deprived of vitamin D by cell size analysis, acridine orange flowcytometry, and the immunohistochemical detection of proteins related to the different stages of differentiation (epidermal calcium binding protein and suprabasal keratins recognized by KL1 antibody) The total keratinocyte and isolated keratinocyte subpopulations were studied. Vitamin D deficiency was associated in the total population with a lower percentage of actively proliferating cells and with a lack of differentiation markers. Study of the isolated cell populations demonstrated, however, that small cells were actively proliferating, whereas they were mainly in the resting stage in the normal epidermis. Treatment with vitamin D dramatically increased cell proliferation and stimulated the appearance of differentiation markers. Some of the observed effects, such as an increase in proliferation and the appearance of epidermal calcium binding protein, were due to the normalisation of the vitamin D deficiency-induced hypocalcemia, whereas the expression of suprabasal keratins was directly dependent on vitamin D. We conclude that the action of vitamin D on the epidermis is associated with increases in both proliferation and differentiation of keratinocytes. Vitamin D itself and its resulting action on calcium homeostasis appear to contribute to the observed effects.
Rougui
Z
Z
CNRS URA 583, Calcium et tissu Osseux dans l'organisme en Développement, Hôpital Necker Enfants-Malades, Paris, France.
Pavlovitch
J
J
Rizk-Rabin
M
M
D000818:Animals; D001835:Body Weight / Q000187:drug effects; D002118:Calcium / Q000378:metabolism / Q000494:pharmacology; D002135:Calcium-Binding Proteins / Q000378:metabolism; D002453:Cell Cycle; D002454:Cell Differentiation / Q000187:drug effects; D002455:Cell Division / Q000187:drug effects; D048429:Cell Size; D000078404:Epidermal Cells; D004817:Epidermis / Q000187:drug effects*; D005434:Flow Cytometry; D006887:Hydroxycholecalciferols / Q000097:blood; D015603:Keratinocytes / Q000166:cytology / Q000187:drug effects*; D008297:Male; D051381:Rats; D017208:Rats, Wistar; D014807:Vitamin D / Q000031:analogs & derivatives / Q000097:blood / Q000494:pharmacology*; D014808:Vitamin D Deficiency / Q000378:metabolism / Q000473:pathology
D002135:Calcium-Binding Proteins; D006887:Hydroxycholecalciferols; D014807:Vitamin D; C097949:1,25-dihydroxyvitamin D; D002118:Calcium